Hippo Holdings Inc.

Fundamentals6.0
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Strong EBITDA
  • Cash-rich balance
  • Working-capital strain

AI
AI Summary

6.0

Hippo has shifted from a growth-at-all-costs insurtech to a technology-enabled specialty insurer now reporting underwriting profitability, so investors should pivot to evaluating the sustainability of combined-ratio improvement and whether accounting profits convert into consistent positive free cash flow. Monitor consecutive quarters with combined ratio ≤100%, clear reserve development (no adverse reserve strengthens), and normalization of receivables/reinsurance mechanics—failure on these metrics would materially increase downside risk.

Earnings
ReserveRisk
HoldWatch‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Strong EBITDA
  • Cash-rich balance
  • Working-capital strain

HIPO is profitable with healthy EBITDA and cash (12% net margin, $57.7M NI, $250M cash, zero debt) and visible future revenue from $579.7M deferred revenue, but faces strained capital structure and working-capital risk (large liabilities and $1.05B receivables), slightly negative free cash flow, and uneven quarterly profitability.

Undervalued
ReceivablesRisk

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Below last month SMA
  • RSI at 30
  • Support testing

HIPO is in a short-term downtrend—the last month SMA is near $26.99 while the 2026-03-20 close at $25.51 sits ~5–6% below, RSI ~30 signals oversold near support $25.10–$25.40 (a sustained break below ~$25.10 would be bearish) and resistance lies at $28.00–$29.50 with reclaiming the last month SMA needed to improve the bias.

bear
HIPO
Support Level: $25.10–$25.40
Resistance Level: $28.00–$29.50

Price ~5–6% below last month

Sentiment & News

6.0

Key News Insights:

  • Improved adjusted EPS
  • Progressive partnership
  • Increased investor scrutiny

Hippo reported improved Q4 adjusted EPS and expanded distribution via an eight-state Progressive partnership, prompting heightened investor scrutiny through its earnings transcript and comparative analyses. ​

distribution
earnings

The EPS pickup and strategic distribution deal should support near-term revenue visibility and investor interest, while comparisons to peers will keep valuation under review